Repeated 7-OH-DPAT treatments: Behavioral sensitization, dopamine synthesis and subsequent sensitivity to apomorphine and cocaine

Psychopharmacology

Volumn 125, Issue 1, 1996, Pages 33-42

  Mattingly, Bruce A ^a   Fields, Sonia E ^a   Langfels, Michael S ^a   Rowlett, James K ^b   Robinet, Patricia M ^c   Bardo, Michael T ^c  

^a MOREHEAD STATE UNIVERSITY   (United States)

^b UNIVERSITY OF MISSISSIPPI SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF KENTUCKY   (United States)

Author keywords

7 OH DPAT; Behavioral sensitization; Cocaine; Cross sensitization; Dopamine D2 type receptors; Dopamine D3 receptors; Locomotor activity

Indexed keywords

2 DIPROPYLAMINO 7 HYDROXYTETRALIN; 2,3,4,5 TETRAHYDRO 7,8 DIHYDROXY 1 PHENYL 1H 3 BENZAZEPINE; 3 HYDROXYBENZYLHYDRAZINE; APOMORPHINE; BROMOCRIPTINE; COCAINE; DOPA; DOPA DECARBOXYLASE INHIBITOR; DOPAMINE; DOPAMINE 2 RECEPTOR STIMULATING AGENT; DOPAMINE 3 RECEPTOR; DOPAMINE 3 RECEPTOR STIMULATING AGENT; DOPAMINE AUTORECEPTOR; QUINPIROLE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BEHAVIOR; BIOSYNTHESIS; BRAIN REGION; CONTROLLED STUDY; CORPUS STRIATUM; CROSS REACTION; DOPAMINE METABOLISM; DOPAMINERGIC SYSTEM; DRUG SENSITIVITY; INTRAPERITONEAL DRUG ADMINISTRATION; LOCOMOTION; MALE; MESOLIMBIC DOPAMINERGIC SYSTEM; NONHUMAN; NUCLEUS ACCUMBENS; OLFACTORY NUCLEUS; PRIORITY JOURNAL; RAT; SENSITIZATION; SUBCUTANEOUS DRUG ADMINISTRATION;

ANIMALS; APOMORPHINE; BEHAVIOR, ANIMAL; COCAINE; DOPAMINE; DOPAMINE AGONISTS; DOSE-RESPONSE RELATIONSHIP, DRUG; LOCOMOTION; MALE; RATS; RATS, WISTAR; TETRAHYDRONAPHTHALENES; TIME FACTORS;

EID: 0029887487     PISSN: 00333158     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02247390     Document Type: Article

References (35)

1. 3 receptor-selective ligand, 7-OH-DPAT, in the normal and the reserpine-treated rat. Eur J Pharmacol 260:177-181
2. 3 preferring ligands on the autoregulation of dopamine (DA) synthesis. Soc Neurosci Abstr 20:284
3. Bannon MJ, Grace AA, Bunney BS, Roth RH (1980) Evidence for an irreversible interaction of bromocryptine with central dopamine receptors. Naunyn-Schmiedeberg's Arch Pharmacol 312:37-41
4. Brown F, Campbell W, Mitchell PJ, Randall K (1985) Dopamine autoreceptors and the effects of drugs on locomotion and dopamine synthesis. Br J Pharmacol 84:853-860
5. 3 agonist. Soc Neurosci Abstr 19:77
6. 3 receptor ligand. Eur J Pharmacol 249: R9-R10
7. Drew KL, Glick SD (1990) Role of D-1 and D-2 receptor stimulation in sensitization to amphetamine-induced circling behavior and in expression and extinction of the pavlovian conditioned response. Psychopharmacology 101:465-471
8. 2 agonist quinpirole on locomotion and movements. Behav Brain Res 34: 151-157
9. Henry DJ, Greene MA, White FJ (1989) Electrophysiological effects of cocaine in the mesoaccumbens dopamine system: repeated administration. J Pharmacol Exp Ther 258: 833-839
10. 2 agonist bromocryptine show environment-specific sensitization following repeated injections. Psychopharmacology 107:277-284
11. Hoffman DC, Wise RA (1993) Lack of cross-sensitization between the locomotor-activating effects of bromocryptine and those of cocaine or heroin. Psychopharmacology 110:402-408
12. Horger BA, Schenk S (1991) Sensitization to cocaine's reinforcing and activating effects: different response to quinpirole preexposure. Soc Neurosci Abstr 17:683
13. Jeziorski M, While FJ (1989) Dopamine agonists at repeated "autoreceptor-selective" doses; effects upon the sensitivity of A10 dopamine autoreceptors. Synapse 4:267-280
14. Kalivas PW, Stewart J (1991) Dopamine transmission in the initiation and expression of drug- and stress-induced sensitizalion of motor activity. Brain Res Rev 16:223-244
15. Kityatkin EA (1994) Enhanced locomotor reactivity to apomorphine following repeated cocaine treatment. Pharmacol Biochem Behav 49:247-251
16. 3H] hydroxy-N,N-di-n-propyl-2-aminotetralin. Proc Natl Acad Sci USA 89: 8155-8159
17. 2 dopamine antagonists on the development of behavioral sensitization to apomorphine. Psychopharmacology 105:501-507
18. Mattingly BA, Rowlett JK, Lovell G (1993) Effects of daily SKF 38393, quinpirole, and SCH 23390 treatments on locomotor activity and subsequent sensitivity to apomorphine. Psychopharmacology 110:320-326
19. 3 receptors. Eur J Pharmacol 249:R9-R10
20. Rebec GV, Lee EH (1983) Differential subsensitivity of dopaminergic and neostriatal neurons to apomorphine with long-term treatment. Brain Res 250:188-192
21. Robinson TE, Becker JB (1986) Enduring changes in brain and behavior produced by chronic amphetamine administration: a review and evaluation of animal models of amphetamine psychosis. Brain Res Rev 11:157-198
22. Rowlett JK, Mattingly BA, Bardo MT (1991) Neurochemical and behavioral effects of acute and chronic treatment with apomorphine in rats. Neurophamacology 30:191-197
23. 1 dopamine receptor stimulation. Synapse 14:160-168
24. Rowlett JK, Mattingly BA, Bardo MT (1995) Repeated quinpirole treatment: locomotor activity, dopamine synthesis, and effects of selective dopamine antagonists. Synapse 20:209-216
25. Schwart JC, Giros B, Matres MP, Sokoloff P (1992) The dopamine receptor family: molecular biology and pharmacology. Semin Neurosci 4:99-108
26. 3) as a novel target for antipsychotic. Biochem Pharmacol 43:659-666
27. Stewart J, Badiani A (1993) Tolerance and sensitization to the behavioral effects of drugs. Behav Pharmacol 4:289-312
28. Stewart J, Vezina P (1989) Microinjections of SCH-23390 into the ventral tegmental area and substantia nigra pars reticulata attenuate the development of sensitization to the locomotor activating effects of systemic amphetamine. Brain Res 495: 401-406
29. Svensson K, Carlsson A, Waters N (1994) Locomotor inhibition by the D3 ligand R-(+)-OH-DPAT is independent of changes in dopamine release. J Neural Transam 95:71-74
30. 2 agonist quinpirole. Soc Neurosci Abstra 15:1157
31. Szechtman H, Talangbayan H, Canaran G, Dai H, Eilam D (1994) Dynamics of behavioral sensitization induced by the dopamine agonist quinpirole and a proposed central energy control mechanism. Psychopharmacology 115:95-104
32. Vezina P, Stewart J (1989) The effect of dopamine receptor blockade on the development of behavioral sensitization to the locomotor activating effects of amphetamine and morphine. Brain Res 499:108-120
33. 3-receptor: a postsynaptic receptor inhibitory on rat locomotor activity. J Neural Transm 94:11-19
34. 2 antagonist raclopride. Synapse 17:155-159
35. Yamada S, Yakoo H, Nishi S (1994) Differential effects of dopamine agonists on evoked dopamine release from slices of striatum and nucleus accumbens in rats. Brain Res 648: 176-179